|
|
||||||||

*
Department of Biochemistry, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, and
Neurotoxicology Laboratories, Department of Pharmacology and Toxicology, Rutgers University, Piscataway, NJ 08854
Stroke is one of the leading causes of death in major industrial
countries. Many factors contribute to the cellular damage resulting
from ischemia/reperfusion (I/R). Experimental data indicate an
important role for oxidative stress and the inflammatory cascade during
I/R. We are testing the hypothesis that the mechanism of protection
against I/R damage observed in transgenic mice overexpressing human
antioxidant enzymes (particularly intracellular glutathione peroxidase)
involves the modulation of inflammatory response as well as reduced
sensitivity of neurons to cytotoxic cytokines. Transgenic animals show
significant reduction of expression of chemokines, IL-6, and cell
death-inducing ligands as well as corresponding receptors in a focal
cerebral I/R model. Reduction of DNA binding activity of consensus and
potential AP-1 binding sites in mouse Fas ligand promoter sequence was
observed in nuclear extracts from transgenic mice overexpressing
intracellular glutathione peroxidase compared with normal animals
following I/R. This effect was accompanied by modulation of the c-Jun
N-terminal kinase/stress-activated protein kinase pathway. Cultured
primary neurons from the transgenic mice demonstrated protection
against hypoxia/reoxygenation injury as well as cytotoxicity after
TNF-
and Fas ligand treatment. These results indicate that
glutathione peroxidase-sensitive reactive oxygen species play an
important role in regulation of cell death during cerebral I/R by
modulating intrinsic neuronal sensitivity as well as brain inflammatory
reactions.
This article has been cited by other articles:
![]() |
H. K. Wang, U. J. Park, S. Y. Kim, J. H. Lee, S. U. Kim, B. J. Gwag, and Y. B. Lee Free Radical Production in CA1 Neurons Induces MIP-1{alpha} Expression, Microglia Recruitment, and Delayed Neuronal Death after Transient Forebrain Ischemia J. Neurosci., February 13, 2008; 28(7): 1721 - 1727. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Thiruchelvam, O. Prokopenko, D. A. Cory-Slechta, E. K. Richfield, B. Buckley, and O. Mirochnitchenko Overexpression of Superoxide Dismutase or Glutathione Peroxidase Protects against the Paraquat + Maneb-induced Parkinson Disease Phenotype J. Biol. Chem., June 10, 2005; 280(23): 22530 - 22539. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Taylor, M. Senchyna, J. Flanagan, E. M. Joyce, D. O. Cliche, A. N. Boone, S. Culp-Stewart, and J. E. Thompson Role of eIF5A in TNF-{alpha}-Mediated Apoptosis of Lamina Cribrosa Cells Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3568 - 3576. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zitzler, D. Link, R. Schafer, W. Liebetrau, M. Kazinski, A. Bonin-Debs, C. Behl, P. Buckel, and U. Brinkmann High-throughput Functional Genomics Identifies Genes That Ameliorate Toxicity Due to Oxidative Stress in Neuronal HT-22 Cells: GFPT2 Protects Cells Against Peroxide Mol. Cell. Proteomics, August 1, 2004; 3(8): 834 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Maier, L. Hsieh, F. Yu, P. Bracci, and P. H. Chan Matrix Metalloproteinase-9 and Myeloperoxidase Expression: Quantitative Analysis by Antigen Immunohistochemistry in a Model of Transient Focal Cerebral Ischemia Stroke, May 1, 2004; 35(5): 1169 - 1174. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Kuan, A. J. Whitmarsh, D. D. Yang, G. Liao, A. J. Schloemer, C. Dong, J. Bao, K. J. Banasiak, G. G. Haddad, R. A. Flavell, et al. A critical role of neural-specific JNK3 for ischemic apoptosis PNAS, December 9, 2003; 100(25): 15184 - 15189. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ding-Zhou, C. Marchand-Verrecchia, B. Palmier, N. Croci, P.-E. Chabrier, M. Plotkine, and I. Margaill Neuroprotective Effects of (S)-N-[4-[4-[(3,4-Dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)carbonyl]-1-piperazinyl]phenyl]-2-thiophenecarboximid-amide (BN 80933), an Inhibitor of Neuronal Nitric-Oxide Synthase and an Antioxidant, in Model of Transient Focal Cerebral Ischemia in Mice J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 588 - 594. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |